John D Sprandio, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 30 Lawrence Rd, Suite 201, Broomall, PA 19008 Phone: 610-492-5900 Fax: 610-492-5810 |
Stephen A Shore, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 30 Lawrence Rd, Suite 201, Broomall, PA 19008 Phone: 610-492-5900 Fax: 610-492-5903 |
Robert K Roush Jr., M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 30 Lawrence Rd, Suite 201, Broomall, PA 19008 Phone: 610-492-5900 Fax: 610-492-5903 |
Peter D Ennis, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 30 Lawrence Rd, Suite 201, Broomall, PA 19008 Phone: 610-492-5900 Fax: 610-492-5903 |
News Archive
Whether you're young or old, the right nutrition can make a difference to your bone health and influence your ability to live an independent, mobile, fracture-free life into your more senior years. That's the key message of a new scientific review published today in the journal 'Osteoporosis International' by leading bone and nutrition experts, in anticipation of World Osteoporosis Day on October 20.
MonoSol Rx, LLC, the developer of PharmFilm® drug delivery technology, today announced that the Company has entered into a development and commercialization partnership with KemPharm, a biopharmaceutical company focused on the discovery and development of new, safer therapies for the treatment of Attention Deficit/Hyperactivity Disorder (ADHD), pain, and cardiovascular disease.
Expertise in fluid mechanics at The University of Akron has attracted funding for a new research center designed to help physicians better diagnose and treat an unusual cause of pain in the head, neck and shoulders. Chiari malformation is a disorder of the neurologic system caused in part by an imbalance in brain and spinal fluid.
The American Academy of Dermatology (AAD) has decided to phase out its AAD SEAL OF RECOGNITION(R) program over the next two years, and will cease accepting new applications effective immediately. Products which were accepted into the program prior to November 15, 2009, will continue to carry the AAD SEAL OF RECOGNITION(R) until the end of their two-year terms.
› Verified 2 days ago